TY - JOUR
T1 - Pharmacotherapy in the treatment of patients with borderline personality disorder
T2 - Results of a survey among psychiatrists in private practices
AU - Knappich, Moritz
AU - Hörz-Sagstetter, Susanne
AU - Schwerthöffer, Dirk
AU - Leucht, Stefan
AU - Rentrop, Michael
PY - 2014/7
Y1 - 2014/7
N2 - Pharmacotherapy still seems to play a major role in the treatment of patients suffering from borderline personality disorder (BPD). However, little is known about psychiatrists' detailed perspective on indication and significance of medication. A total of 233 psychiatrists in the city of Munich and in Upper Bavaria were asked by questionnaire about their treatment habits in the medical treatment of patients with BPD. One hundred and forty-one psychiatrists answered the questionnaire (60.5%). In total, 94% of BPD patients were treated with psychotropic medication. Psychiatrists predominantly saw an indication to prescribe antidepressants (98%), followed by antipsychotics, mood stabilizers, and benzodiazepines. Citalopram/escitalopram and quetiapine were mentioned most frequently. The results are discussed in conjunction with the international guidelines for the treatment of BPD.
AB - Pharmacotherapy still seems to play a major role in the treatment of patients suffering from borderline personality disorder (BPD). However, little is known about psychiatrists' detailed perspective on indication and significance of medication. A total of 233 psychiatrists in the city of Munich and in Upper Bavaria were asked by questionnaire about their treatment habits in the medical treatment of patients with BPD. One hundred and forty-one psychiatrists answered the questionnaire (60.5%). In total, 94% of BPD patients were treated with psychotropic medication. Psychiatrists predominantly saw an indication to prescribe antidepressants (98%), followed by antipsychotics, mood stabilizers, and benzodiazepines. Citalopram/escitalopram and quetiapine were mentioned most frequently. The results are discussed in conjunction with the international guidelines for the treatment of BPD.
KW - borderline personality disorder
KW - pharmacological treatment
KW - questionnaire
KW - treatment guidelines
UR - http://www.scopus.com/inward/record.url?scp=84902076087&partnerID=8YFLogxK
U2 - 10.1097/YIC.0000000000000021
DO - 10.1097/YIC.0000000000000021
M3 - Article
C2 - 24896541
AN - SCOPUS:84902076087
SN - 0268-1315
VL - 29
SP - 224
EP - 228
JO - International Clinical Psychopharmacology
JF - International Clinical Psychopharmacology
IS - 4
ER -
